Publication:
Comparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia

Simple item page
dc.contributor.authorTaneli, B
dc.contributor.authorAlptekin, K
dc.contributor.authorBilici, M
dc.contributor.authorBirsoz, S
dc.contributor.authorEker, E
dc.contributor.authorCosar, B
dc.contributor.authorGoka, E
dc.contributor.authorGöktepe, E
dc.contributor.authorGüz, H
dc.contributor.authorKaramustafalioğlu, O.
dc.contributor.authorKültür, S
dc.contributor.authorLevent, B. A.
dc.contributor.authorÖnder, E.
dc.contributor.authorOral, T.
dc.contributor.authorÖzşahin, A. Ö.
dc.contributor.authorVeznedaroğlu, B.
dc.contributor.authorYüksel, S.
dc.contributor.authorYurtseven, N.
dc.contributor.buuauthorTaneli, B
dc.contributor.buuauthorAlptekin, K
dc.contributor.buuauthorBilici, M
dc.contributor.buuauthorBirsöz, S
dc.contributor.buuauthorEker, E
dc.contributor.buuauthorCOŞAR ERTEM, AYTÜL
dc.contributor.buuauthorGöka, E
dc.contributor.buuauthorGöktepe, E
dc.contributor.buuauthorGüz, H
dc.contributor.buuauthorKaramustafalıoğlu, O.
dc.contributor.buuauthorKültür, S.
dc.contributor.buuauthorLevent, B. A.
dc.contributor.buuauthorÇAMOĞLU, ENİS ÖNDER
dc.contributor.buuauthorOral, T.
dc.contributor.buuauthorÖzşahin, A. Ö.
dc.contributor.buuauthorVeznedaroğlu, B.
dc.contributor.buuauthorYüksel, S.
dc.contributor.buuauthorYurtseven, N.
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentPsikiyatri Bölümü
dc.contributor.orcid0000-0002-7601-9002
dc.contributor.orcid0000-0002-6422-499X
dc.contributor.researcheridAFV-5578-2022
dc.contributor.researcheridKBR-3031-2024
dc.contributor.researcheridAAD-9284-2019
dc.contributor.researcheridGPS-8862-2022
dc.contributor.researcheridDZC-3645-2022
dc.contributor.researcheridEPA-9227-2022
dc.contributor.researcheridJRJ-6923-2023
dc.contributor.researcheridESK-4872-2022
dc.contributor.researcheridCRC-5171-2022
dc.contributor.researcheridEYB-9548-2022
dc.contributor.researcheridFGH-9600-2022
dc.contributor.researcheridFIO-8437-2022
dc.contributor.researcheridJQZ-7959-2023
dc.contributor.researcheridDJW-0629-2022
dc.contributor.researcheridDLP-7456-2022
dc.contributor.researcheridEFC-5764-2022
dc.contributor.researcheridHKB-6683-2023
dc.contributor.researcheridGRT-2215-2022
dc.date.accessioned2024-11-26T08:17:47Z
dc.date.available2024-11-26T08:17:47Z
dc.date.issued2003-09-01
dc.descriptionBu çalışma, 20-24, Eylül 2003 tarihlerinde Location PRAGUE[Çek Cumhuriyetin]’de düzenlenen 16. Congress of the European-College-of-Neuropsychopharmacology Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Coll Neuropsychopharmacol
dc.identifier.endpageS287
dc.identifier.issn0924-977X
dc.identifier.startpageS287
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0924977X03919730
dc.identifier.urihttps://hdl.handle.net/11452/48495
dc.identifier.volume13
dc.identifier.wos000185412300379
dc.indexed.wosWOS.ISTP
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherElsevier
dc.relation.journalEuropean Neuropsychopharmacology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectClinical neurology
dc.subjectNeurosciences
dc.subjectPharmacology & pharmacy
dc.subjectPsychiatry
dc.subjectNeurosciences & neurology
dc.titleComparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Psikiyatri Bölümü
relation.isAuthorOfPublicationdd755111-6c76-47c3-841d-0c627a7c6e0f
relation.isAuthorOfPublication5198fa9e-805a-4957-bea1-6f506275dcbe
relation.isAuthorOfPublication.latestForDiscoverydd755111-6c76-47c3-841d-0c627a7c6e0f

Files

Collections

Yeni Yayınlar